SIGIDA duo

Ophthalmology
Photo Product SIGIDA duo Multidose 0.1% + 0.033% - Solopharm

Indications for use

  • Exacerbation of seasonal or perennial allergic conjunctivitis;
  • Inflammatory conditions related to irritation of the conjunctiva as a result of contact lens use, exposure to sunlight, cigarette smoke, contact with water in a swimming pool, etc.

Therapeutic class:

Co-formulated antisensitizer (Histamine 1 receptor antagonist + Alpha-adrenergic agonist)

INN

Naphazoline + diphenhydramine

OSD bottle

Back to catalog